The Evidence Doesn’t Justify Steps By State Medicaid Programs To Restrict Opioid Addiction Treatment With Buprenorphine

Some state Medicaid programs have restricted access to buprenorphine because of costs and a fear that it may be less safe than other therapies such as methadone.